This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 May 7;382(19):1851-1852.

doi: 10.1056/NEJMe2005477. Epub 2020 Mar 18.

Covid-19 - The Search for Effective Therapy

Lindsey R Baden, Eric J Rubin

PMID: 32187463
PMCID: PMC7121446
DOI: 10.1056/NEJMe2005477

Free PMC article

Editorial

Covid-19 - The Search for Effective Therapy

Lindsey R Baden et al. N Engl J Med. 2020.

Free PMC article

. 2020 May 7;382(19):1851-1852.

doi: 10.1056/NEJMe2005477. Epub 2020 Mar 18.

Authors

Lindsey R Baden, Eric J Rubin

PMID: 32187463
PMCID: PMC7121446
DOI: 10.1056/NEJMe2005477

No abstract available

PubMed Disclaimer

Comment on

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. Cao B, et al. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18. N Engl J Med. 2020. PMID: 32187464 Free PMC article. Clinical Trial.

Similar articles

Early triple antiviral therapy for COVID-19.
Lee N, Ison M, Dunning J. Lee N, et al. Lancet. 2020 Nov 7;396(10261):1487-1488. doi: 10.1016/S0140-6736(20)32274-1. Lancet. 2020. PMID: 33160566 Free PMC article. No abstract available.
Early triple antiviral therapy for COVID-19 - Authors' reply.
Hung IF, Yuen KY. Hung IF, et al. Lancet. 2020 Nov 7;396(10261):1488. doi: 10.1016/S0140-6736(20)32268-6. Lancet. 2020. PMID: 33160568 Free PMC article. No abstract available.
Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?
Owa AB, Owa OT. Owa AB, et al. J Microbiol Immunol Infect. 2020 Oct;53(5):674-675. doi: 10.1016/j.jmii.2020.05.014. Epub 2020 May 25. J Microbiol Immunol Infect. 2020. PMID: 32474026 Free PMC article.
[Potential therapeutic drugs for novel coronavirus pneumonia].
Nie NF, He Y. Nie NF, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2020 Nov 12;43(11):970-974. doi: 10.3760/cma.j.cn112147-20200226-00191. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 33137863 Review. Chinese.
Antiviral treatment of COVID-19.
Şimşek Yavuz S, Ünal S. Şimşek Yavuz S, et al. Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619. doi: 10.3906/sag-2004-145. Turk J Med Sci. 2020. PMID: 32293834 Free PMC article. Review.

See all similar articles

Cited by

Acute and subacute oral toxicity characterization and safety assessment of COVID organics^® (Madagascar's Anti-COVID Herbal Tea) in animal models.
Aina OO, Okoyenta OC, Okolo CA, Kareem KO, Ajibaye O, Adeogun AO, Salako BL. Aina OO, et al. Ann Afr Med. 2023 Oct-Dec;22(4):481-488. doi: 10.4103/aam.aam_112_21. Ann Afr Med. 2023. PMID: 38358149 Free PMC article.
Ritonavir Has Reproductive Toxicity Depending on Disrupting PI3K/PDK1/AKT Signaling Pathway.
Jung EJ, Jo JH, Uwamahoro C, Jang SI, Lee WJ, Hwang JM, Bae JW, Kwon WS. Jung EJ, et al. Toxics. 2024 Jan 15;12(1):73. doi: 10.3390/toxics12010073. Toxics. 2024. PMID: 38251029 Free PMC article.
A Comparative Study of Antiretroviral (Lopinavir/Ritonavir) and Remdesivir Used in the Pandemic in Iraq on the Clinical Outcome in Patients with SARS-CoV-2.
Alabdalaali MM, Hadi AM. Alabdalaali MM, et al. Arch Razi Inst. 2023 Jun 30;78(3):935-941. doi: 10.22092/ARI.2022.360354.2574. eCollection 2023 Jun. Arch Razi Inst. 2023. PMID: 38028857 Free PMC article.
COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development.
Bostanghadiri N, Ziaeefar P, Mofrad MG, Yousefzadeh P, Hashemi A, Darban-Sarokhalil D. Bostanghadiri N, et al. Biomed Res Int. 2023 Aug 29;2023:1879554. doi: 10.1155/2023/1879554. eCollection 2023. Biomed Res Int. 2023. PMID: 37674935 Free PMC article. Review.
Metabolome and transcriptome analyses identify the characteristics and expression of related saponins of the three genealogical plants of bead ginseng.
Ye Y, Ma N, Peng Y, Chen Y, Zhang Y, Zhao S, Ren W, Yan Y, Zhang G, Yang X, Peng X. Ye Y, et al. PeerJ. 2023 Sep 1;11:e16034. doi: 10.7717/peerj.16034. eCollection 2023. PeerJ. 2023. PMID: 37671355 Free PMC article.

See all "Cited by" articles

References

1. Sheahan TP, Sims AC, Leist SR, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Comm 2020;11:222-222. - PMC - PubMed
1. Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2001282. - DOI - PMC - PubMed
1. Baden LR, Rubin EJ, Morrissey S, Farrar JJ, Drazen JM. We can do better — improving outcomes in the midst of an emergency. N Engl J Med 2017;377:1482-1484. - PubMed
1. Lopinavir/ritonavir (Kaletra). North Chicago, IL: AbbVie, 2019. (https://www.rxabbvie.com/pdf/kaletracap_PI.pdf) (prescribing information).

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations